Trial Profile
Multicenter Randomized Prospective Controlled Trial of antiviral Treatment in patients with Severe Influenza A Infection
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary) ; Peramivir
- Indications Influenza A virus H1N1 subtype; Influenza A virus H5N1 subtype; Influenza A virus H7N9 subtype; Influenza A virus infections
- Focus Therapeutic Use
- 14 Aug 2014 New trial record